CYP19A1 and endometriosis: Treatment for endometriosis must involve interventions that can modulate the multidimensional nature of the disease, which involves inflammatory (IL-6, TNF-α, CCL2), hormonal (ERβ, aromatase, 17β-estradiol) and oxidative (MDA, ROS, SOD/GPx) factors.